Heritage Medical Systems has backed a $25m series B round for the Caltech spinout, which is developing therapies for Parkinson’s and Autism spectrum disorder.
US-based biopharmaceutical company Axial Biotherapeutics completed a $25m series B round yesterday that included a commitment from healthcare provider Heritage Medical Systems.
Health for Life Capital, a fund managed by Seventure Partners, led the round, investing alongside investment managers Longwood Fund and Domain Associates, as well a group of high-net-worth individuals based in Southern California.
Axial is developing treatments for central nervous system disorders by targeting the connections between the brain and the human gut microbiome. The company…
